This is a working overview of circadian rhythm, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-07-24. Anything still debated is marked as such rather than presented as settled.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
| Property | Value | Notes |
|---|---|---|
| Common name | SR9009 | Also referred to as Stenabolic in non-scientific contexts. |
| Chemical class | Synthetic small molecule | Not a steroid or peptide hormone. |
| Receptor target | REV-ERBα and REV-ERBβ | Nuclear receptor agonist in preclinical studies. |
| Development status | Investigational | No approved human therapeutic indication. |
| Regulatory attention | Prohibited in sport | Listed by anti-doping authorities. |
For long-term storage, SR9009 is typically kept as a solid at low temperature, protected from moisture and light. Desiccated conditions limit hydrolysis, while opaque containers reduce photochemical breakdown. Solutions are less stable than solids and are often stored frozen in aliquots to avoid repeated freeze-thaw cycles. Stability data are not standardized across all suppliers, so users should rely on certificate-of-analysis information when available. Degradation may appear as color change, precipitate, or decreased chromatographic purity.
Laboratory identification of SR9009 typically relies on chromatographic separation coupled to mass spectrometry, often with ultraviolet detection as a secondary check. Nuclear magnetic resonance spectroscopy can confirm molecular structure when a reference standard is available. Because many suppliers sell the compound as a research chemical, independent identity testing is important for experimental reproducibility. A single retention time is not sufficient proof of identity, especially when related compounds may be present. Purity assessments usually report a percentage based on area normalization.
SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.
Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
This infuriated American colonists and led to the Boston Tea Party, where 90,000 pounds of EIC tea were dumped into the Boston Harbor. As news spread, tea was destroyed throughout the colonies. In Greenwich New Jersey for example, chests of tea were burned in Market Square. As a consequence of these acts and the American revolution (1765–1791), tea drinking became seen as unpatriotic. One article in the Boston Gazette on 15 August, 1768 stated: “Let us abjure the poisonous baneful plant and its odious infusion – poisonous and odious, I mean, not on account of its physical qualities but on account of the political diseases and death that are connected with every particle of it.” Boycotts of tea by revolutionary patriots led to an increase in consumption of other beverages, such as coffee, yaupon tea, or herbal teas infused with peppermint, sage or dandelions. In spite of the distaste for tea that was fueled by the revolution, tea continued to be used by Americans, especially after the war. For example, George Washington regularly had tea for breakfast and dinner, in the English fashion. American merchants Samuel Shaw and Robert Morris sent the first merchant ship to China (the Empress of China) and soon Chinese tea was being shipped to America by American merchant vessels.
=== Adobe ColdFusion 8 === On July 30, 2007, Adobe Systems released ColdFusion 8, dropping "MX" from its name. During beta testing the codename used was "Scorpio" (the eighth sign of the zodiac and the eighth iteration of ColdFusion as a commercial product). More than 14,000 developers worldwide were active in the beta process - many more testers than the 5,000 Adobe Systems originally expected. The ColdFusion development team consisted of developers based in Newton/Boston, Massachusetts and offshore in Bangalore, India. Some of the new features are the CFPDFFORM tag, which enables integration with Adobe Acrobat forms, some image manipulation functions, Microsoft .NET integration, and the CFPRESENTATION tag, which allows the creation of dynamic presentations using Adobe Acrobat Connect, the Web-based collaboration solution formerly known as Macromedia Breeze. In addition, the ColdFusion Administrator for the Enterprise version ships with built-in server monitoring. ColdFusion 8 is available on several operating systems including Linux, Mac OS X and Windows Server 2003.
=== Emergency treatment === At present, there are no specific antidotes for NBOMes, and all acute intoxication is managed by symptomatic treatments, such as administration of benzodiazepines, antipsychotic drugs, and antiarrhythmic agents, such as beta blockers; some emergency interventions are intended to specifically treat rhabdomyolysis, which may lead to critical complications such as metabolic acidosis and acute kidney injury.
Jennifer Phang ( PONG) is an American filmmaker (writer, director, producer), most known for her feature films Advantageous (2015) and Half-Life (2008). Advantageous premiered at the 2015 Sundance Film Festival, winning a Special Jury Award for Collaborative Vision, and was based on her award-winning short film of the same name. Half-Life premiered at the 2008 Sundance Film Festival and won "Best Film" awards at a number of film festivals including the Gen Art Film Festival, the San Francisco International Asian American Film Festival (now known as CAAMFest) as well as an "Emerging Director Award" at the Asian American International Film Festival.
=== List of side effects === Cardiovascular: Myocardial infarction; stroke; heart block; arrhythmias; hypotension, particularly orthostatic hypotension; hypertension; tachycardia; palpitation. Psychiatric: Confusional states (especially in the elderly) with hallucinations, disorientation, delusions, anxiety, restlessness, agitation; hypomania; exacerbation of psychosis; insomnia, panic, and nightmares. Neurological: Seizures; incoordination; ataxia; tremors; peripheral neuropathy; numbness, tingling, and paresthesias of extremities; extrapyramidal symptoms; drowsiness; dizziness; weakness and fatigue; headache; syndrome of inappropriate ADH (antidiuretic hormone) secretion; tinnitus; alteration in EEG patterns. Anticholinergic: Paralytic ileus; hyperpyrexia; urinary retention, delayed micturition, dilatation of the urinary tract; constipation; blurred vision, disturbance of accommodation, increased intraocular pressure, mydriasis; dry mouth and rarely associated sublingual adentitis. Allergic: Drug fever; petechiae, skin rash, urticaria, itching, photosensitization (avoid excessive exposure to sunlight); edema (general, or of face and tongue). Hematologic: Agranulocytosis; bone marrow depression; leukopenia;thrombocytopenia; purpura; eosinophilia. Gastrointestinal: Nausea and vomiting; anorexia; epigastric distress; diarrhea; peculiar taste; stomatitis; abdominal cramps; black tongue.
Sources: en.wikipedia.org
In 80–85% of cases, the ALK detected in ALK-positive ALCL is a NPM1-ALK fusion protein. It is made by a fusion of NPM1 gene, which makes nucleophosmin 1, located on the long or "q" arm of chromosome 5 at position 35 (notated as 5q35) with the ALK gene located on the short or "p" arm of chromosome 2 at position 23 (notated as 2p23) to form a chimeric gene notated as (2;5)(p23;q35). In 13% of cases ALK fuses with the TPM3 gene or in <1% of cases for each of the following genes: TFG, ATIC, CLTC, TPM4, MSN, RNF213 (also termed ALO17), MYH9, or TRAF1. All of these fusion proteins are considered to act like NPMI-ALK in possessing high ALK activity that promotes the development and progression ALK-positive ALCL by activating the cell signaling pathways cited in the Introduction. 15% Of individuals with ALK-positive ALCL also have point mutations in the NOTCH1 gene. While most of these abnormalities are thought to be detrimental not all are. For example, DUSP22 gene rearrangements are associated with favorable outcomes in ALK-positive (as well as ALK-negative) ALCL.
Neutron capture reactions (n,γ), which are represented in the figure by a short right arrow. The (n,2n) reactions and the less frequently occurring (γ,n) reactions are also taken into account, both of which are marked by a short left arrow. Even more rarely and only triggered by fast neutrons, the (n,3n) reaction occurs, which is represented in the figure with one example, marked by a long left arrow. In addition to these neutron- or gamma-induced nuclear reactions, the radioactive conversion of actinide nuclides also affects the nuclide inventory in a reactor. These decay types are marked in the figure by diagonal arrows. The beta-minus decay, marked with an arrow pointing up-left, plays a major role for the balance of the particle densities of the nuclides. Nuclides decaying by positron emission (beta-plus decay) or electron capture (ϵ) do not occur in a nuclear reactor except as products of knockout reactions; their decays are marked with arrows pointing down-right. Due to the long half-lives of the given nuclides, alpha decay plays almost no role in the formation and decay of the actinides in a power reactor, as the residence time of the nuclear fuel in the reactor core is rather short (a few years). Exceptions are the two relatively short-lived nuclides 242Cm (T1/2 = 163 d) and 236Pu (T1/2 = 2.9 y). Only for these two cases, the α decay is marked on the nuclide map by a long arrow pointing down-left.
== Veterinary uses == The data from two six-month field studies and an extended use field study demonstrated that bexagliflozin was over 80% effective in improving glycemic control in cats with diabetes mellitus. Bexagliflozin, sold under the brand name Bexacat, is an antidiabetic medication used to improve glycemic control in cats with diabetes. Bexacat is the first sodium-glucose cotransporter 2 (SGLT2) inhibitor new animal drug approved by the US Food and Drug Administration (FDA) in any animal species. It was approved for medical use in the United States in December 2022. Bexacat is sponsored by Increvet Inc., based in Boston, Massachusetts. Elanco licensed development and commercialization rights for bexagliflozin from Bexcafe, an affiliate of Increvet.
In July 2017, Matthew Bryza stated at the conference in Warsaw: "President Putin was preparing to invade Georgia. Those preparations went on for years, and when I would ring the alarm bell I would often be told that I should focus more on managing President Saakashvili [...] At one point, it was no longer possible to calm down Saakashvili, Russian troops poured into Georgia, Saakashvili ended up getting blamed by the international narrative for having launched the war. I'll go to my grave thinking it was absolutely wrong based on the intelligence I was reading, it was a provocation by Russia." In 2018, former Polish ambassador to Russia Katarzyna Pełczyńska-Nałęcz stated during a discussion that "the whole situation of this war was such that it really was very difficult to explain that the Russians actually attacked.
== Treatment == If nipple pain is not resolved effectively after general management, appropriate treatment can be directed at underlying causes. Nevertheless, except the general management mentioned before, all common therapeutic practices in treating nipple pain during breastfeeding are not proven to be effective yet.
Sources: en.wikipedia.org
Firefox Missile Command Raid over Moscow SDI Metal Gear Solid 3: Snake Eater Metal Gear Solid V: The Phantom Pain DEFCON World in Conflict Crisis in the Kremlin Call of Duty: Black Ops Call of Duty: Black Ops: Declassified Call of Duty: Black Ops II Call of Duty: Black Ops Cold War Fallout (series) Command and Conquer: Red Alert Tetris
The human body contains, on average, 50–60% water, depending on age, gender and body size, although individuals may have anywhere between 45% and 75%. The U.S. National Academies of Sciences, Engineering, and Medicine recommends a daily intake of 3.7 liters (0.98 U.S. gallons) of water for adult men and 2.7 L (0.71 U.S. gal) for women. The precise amount depends on the level of activity, temperature, humidity, and other factors. Most of this is ingested through foods or beverages other than drinking straight water. Medical literature favors a lower consumption, typically 1 liter of water for an average male, excluding extra requirements due to fluid loss from exercise or warm weather. Healthy kidneys can excrete 0.8 to 1 liter of water per hour, but stress such as exercise can reduce this amount. People can drink far more water than necessary while exercising, putting them at risk of water intoxication (hyperhydration), which can be fatal. The popular claim that "a person should consume eight glasses of water per day" seems to have no real basis in science. Studies have shown that extra water intake, especially up to 500 millilitres (18 imp fl oz; 17 US fl oz) at mealtime, was associated with weight loss. Adequate fluid intake is helpful in preventing constipation.
==== 2020 ==== Scientists report, using public biological data on 1.75 m people with known lifespans overall, to have identified 10 genomic loci which appear to intrinsically influence healthspan, lifespan, and longevity – of which half have not been reported previously at genome-wide significance and most being associated with cardiovascular disease – as well as haem metabolism as a promising candidate for further research within the field. Scientists report that after mice exercise their livers secrete the protein GPLD1, which is also elevated in elderly humans who exercise regularly, that this is associated with improved cognitive function in aged mice and that increasing the amount of GPLD1 produced by the mouse liver in old mice could yield many benefits of regular exercise for their brains – such as increased BDNF-levels, neurogenesis, and improved cognitive functioning in tests. Scientists report that yeast cells of the same genetic material and within the same environment age in two distinct ways, describe a biomolecular mechanism that can determine which process dominates during aging and genetically engineer a novel aging route with substantially extended lifespan. Reprogramming progress Scientists show that expression of nuclear reprogramming factors can lead to rapid and broad amelioration of cellular aging. A study shows that reprogramming induced with the OSK-genes can restore youthful epigenetic patterns as well as revert age-related vision loss.
=== In LTP === When alpha-CaMKII is knocked out in mice, LTP is reduced by 50%. This can be explained by the fact that beta-CaMKII is responsible for approximately 65% of CaMKII activity. LTP can be completely blocked if CaMKII is modified so that it cannot remain active. After LTP induction, CaMKII moves to the postsynaptic density (PSD). However, if the stimulation does not induce LTP, the translocation is quickly reversible. Binding to the PSD changes CaMKII so that it is less likely to become dephosphorylated. CaMKII transforms from a substrate for Protein Phosphatase 2A (PP2A), which is responsible for dephosphorylating CaMKII, to that of Protein Phosphatase 1. Strack, S. (1997) demonstrated this phenomenon by chemically stimulating hippocampal slices. This experiment illustrates that CaMKII contributes to the enhancement of synaptic strength. Sanhueza et al. found that persistent activation of CaMKII is necessary for the maintenance of LTP. She induced LTP in hippocampal slices and experimentally applied an antagonist (CaMKIINtide) to prevent CaMKII from remaining active. The slices that were applied with CaMKIINtide showed a decrease in Normalized EPSP slope after the drug infusion, meaning that the induced LTP reversed itself. The Normalized EPSP slope remained constant in the control; CaMKII continues to be involved in the LTP maintenance process even after LTP establishment. CaMKII is activated by calcium/calmodulin, but it is maintained by autophosphorylation. CaMKII is activated by the NMDA-receptor-mediated Calcium elevation that occurs during LTP induction.
Sources: en.wikipedia.org
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.
No. It is a small molecule that binds nuclear receptors involved in circadian regulation. Its classification differs from anabolic steroids or peptide hormones.
Published human clinical trial data are lacking. Most safety and activity information comes from preclinical models, so effects in people remain uncertain.
SR9009 is a synthetic compound investigated as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is used in preclinical research on circadian rhythm and metabolism. It is not an approved drug.